Brief Summary
Type:
Multiple Sites (Solid Tumors)
Study Type:
Prevention
Phase:
III
ClinicalTrials.gov Identifier:
NCT04089358
Study #:
cmh - ALTE2031
Start Date:
Nov 10, 2021
Full Details and Eligibility at clinicaltrials.gov
By taking part in a clinical trial, you have access to potentially effective treatments not available elsewhere. Additionally, you will contribute to cancer research, which can help other cancer patients in the future. Read the full details of this specific clinical trial by clicking on the link below.
ClinicalTrials.gov ID: NCT04089358
View Complete Trial Details & Eligibility at ClinicalTrials.gov
